Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02011295 · ClinicalTrials.gov registry record · NA
Bone Marrow Aspirate Concentrate (BMAC) Supplementation for Osteochondral Lesions
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT02011295 is a NA study that has completed, run by Duke University. The registered enrollment target is 17 participants.
The verdict
NCT02011295, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the clinical efficacy of the application of bone marrow aspirate concentrate (BMAC) as a supplement to microfracture in the treatment of osteochondral lesions of the talus (OLTs).
Interventions
- PROCEDURE ankle arthroscopy with debridement and microfracture of the OLT
- OTHER Bone Marrow Aspirate injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2014-01-29 |
| Est. Completion | 2019-06-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02011295
The ClinicalTrials.gov registry entry for NCT02011295 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ankle arthroscopy with debridement and microfracture of the OLT is the first listed.
NCT02011295 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02011295 about?
NCT02011295 is a clinical study titled "Bone Marrow Aspirate Concentrate (BMAC) Supplementation for Osteochondral Lesions". The purpose of this study is to determine the clinical efficacy of the application of bone marrow aspirate concentrate (BMAC) as a supplement to microfracture in the treatment of osteochondral lesions of the talus (OLTs).
What is the current status of trial NCT02011295?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2014-01-29. Estimated completion is 2019-06-26.
What interventions are being tested in trial NCT02011295?
The interventions under investigation include: ankle arthroscopy with debridement and microfracture of the OLT (PROCEDURE), Bone Marrow Aspirate injection (OTHER).
Who is sponsoring clinical trial NCT02011295?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.